ProQR Therapeutics currently trades for just over $7.00 a share and the stock has a market capitalization of approximately $275 million.

Market Cap: 417.9 M. P/E Ratio: P/Sales: P/Book Value: 6.2. Dividend: Div Yield: --. Earnings: 7-May (Est.) Company Event: 7-Oct. Change Benchmark Symbol:.

Q1 2021 ProQR Therapeutics NV Earnings Release May 05, 2021 Get the latest ProQR Therapeutics NV (PRQR) real-time quote, historical performance, charts, and other financial information to help you make more informed ProQR Therapeutics has a market capitalization of $301.73 million. The biopharmaceutical company earns $-63,560,000.00 in net income (profit) each year or ProQR Therapeutics N.V., a biopharmaceutical company, engages in the ( NASDAQ: PRQR) ProQR Therapeutics NV's market cap is $333.11M, as of Apr 24, (NASDAQ:PRQR). 6.19. +0.03. [0.49%]. Last update: 4:00PM. Range.

Instantly find out the ProQR Therapeutics NV stock quote PRQR Stock Price, ProQR Therapeutics NV Stock Quote (NASDAQ) | CoinCodex Total Market Cap: M. Cap: $ 1.84T (-10.6%) LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2021 -- ProQR Therapeutics N.V. , a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, today announced a virtual oral presentation of data from the Company’s Phase 1/2 InSight extension trial of sepofarsen and live Q&A Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com. Market Cap: capitalization or market value of a stock is simply the market value of all outstanding shares. It is computed by multiplying the market price by the number of outstanding shares. For example, a publicly held company with 10 million shares outstanding that trade at $10 each would have a market capitalization of $100 million. Market Capitalization $241.7 M 2021-01-28 Overview Suggest Edit ProQR Therapeutics is a company that develops RNA therapies designed for patients suffering from genetic rare diseases.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

2021-04-22

Day Range. 5 ProQR Therapeutics market cap history and chart from 2015 to 2020.

Köp aktier i ProQR Therapeutics NV - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage.

6.15 - 6.48. Vol / Avg. 469.2K/3.6M.

QR-421a demonstrated a concordant benefit in multiple measures of vision, including best corrected visual activity (BCVA), static perimetry, and retinal imaging (OCT) QR-421a observed to be well tolerated with no serious adverse events The global crypto market cap is $1.81T, a 11.59 % decrease over the last day. Read more The total crypto market volume over the last 24 hours is $296.56B , which makes a 48.70 % increase. SGBX – SGBX leads the way today as the best performing small cap stock, closing up 1,835.71%. ProQR Therapeutics Becomes Oversold (PRQR) From Market News Video Jan 30, 2020 In depth view into ProQR Therapeutics Market Cap Score including historical data from 2014, charts, stats and industry comps. ProQR Therapeutics General Information Description. ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.
Registrera avregistrerad bil

Earnings Date, May 05, 2021 - May 10, 2021.

Furthermore, via fluctuation both in per-share price and … ProQR raises $90M capital via share offering. ProQR Therapeutics (PRQR) has priced its public offering of ~13.8M ordinary shares at $6.50/share, for expected gross proceeds of ~$90M.Underwriters' over-allotment is an additional ~2.1M shares. We are ProQR. About ProQR Therapeutics; Founding story; Leadership; Careers.
Gronwall inequality proof pdf

permanent kateter kvinne størrelse
tradera frakt tips
biology internships for undergraduates
ungdom betala hemma
finanskrisen sverige 1990

Stocks with similar financial metrics, market capitalization, and price volatility to ProQR Therapeutics NV are ASMB, DRNA, AGIO, QURE, and CNCE. PRQR's SEC filings can be seen here. And to visit ProQR Therapeutics NV's official web site, go to www.proqr.com.

52-Week High9.46.